Jason T. Huse

31.2k total citations · 9 hit papers
131 papers, 12.3k citations indexed

About

Jason T. Huse is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Jason T. Huse has authored 131 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Genetics, 66 papers in Molecular Biology and 41 papers in Cancer Research. Recurrent topics in Jason T. Huse's work include Glioma Diagnosis and Treatment (77 papers), MicroRNA in disease regulation (20 papers) and Neuroblastoma Research and Treatments (14 papers). Jason T. Huse is often cited by papers focused on Glioma Diagnosis and Treatment (77 papers), MicroRNA in disease regulation (20 papers) and Neuroblastoma Research and Treatments (14 papers). Jason T. Huse collaborates with scholars based in United States, Netherlands and China. Jason T. Huse's co-authors include Eric C. Holland, Cameron Brennan, Johanna A. Joyce, Leila Akkari, Daniela F. Quail, Robert L. Bowman, James Sutton, Marsha L. Quick, Alberto J. Schuhmacher and Dolores Hambardzumyan and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Jason T. Huse

125 papers receiving 12.2k citations

Hit Papers

CSF-1R inhibition alters macrophage polarization and bloc... 2009 2026 2014 2020 2013 2012 2009 2010 2016 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CSF-1R inhibition alters macrophage polarization and blocks glioma progression
    2013 1.8k citations Leila Akkari, Robert L. Bowman et al. profile →
  2. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
    2012 1.4k citations Carl Campos, Adriana Heguy et al. profile →
  3. PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
    2009 644 citations Dolores Hambardzumyan, Elena I. Fomchenko et al. profile →
  4. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
    2010 587 citations Jason T. Huse, Eric C. Holland profile →
  5. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
    2016 519 citations Daniela F. Quail, Robert L. Bowman et al. profile →
  6. Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth
    2014 403 citations Alexander Pietras, Amanda Katz et al. profile →
  7. Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
    2017 308 citations Jason T. Huse et al. Neuro-Oncology profile →
  8. YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis
    2020 298 citations Jason T. Huse, Leng Han et al. profile →
  9. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
    2018 287 citations Jason T. Huse et al. profile →

Peers

Jason T. Huse
Howard Colman United States
Qiulian Wu United States
Richard J. Gilbertson United States
Anita B. Hjelmeland United States
Gaetano Finocchiaro Italy
Frank B. Furnari United States
Marie‐France Hamou Switzerland
Donald M. O’Rourke United States
Robert M. Prins United States
Sheila K. Singh Canada
Howard Colman United States
Jason T. Huse
Citations per year, relative to Jason T. Huse Jason T. Huse (= 1×) peers Howard Colman

Countries citing papers authored by Jason T. Huse

Since Specialization
Citations

This map shows the geographic impact of Jason T. Huse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason T. Huse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason T. Huse more than expected).

Fields of papers citing papers by Jason T. Huse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason T. Huse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason T. Huse. The network helps show where Jason T. Huse may publish in the future.

Co-authorship network of co-authors of Jason T. Huse

This figure shows the co-authorship network connecting the top 25 collaborators of Jason T. Huse. A scholar is included among the top collaborators of Jason T. Huse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason T. Huse. Jason T. Huse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yan‐Yan, Shuyu Chen, Xiwen Yang, et al.. (2025). Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer. Cancer Research. 85(8). 1530–1543. 2 indexed citations
2.
3.
Denu, Ryan A., Ahsan Farooqi, Davis R. Ingram, et al.. (2024). Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.. Journal of Clinical Oncology. 42(16_suppl). 11511–11511. 2 indexed citations
4.
Lu, Lina, Kazutaka Fukumura, Hsiao‐Yun Lin, et al.. (2023). High throughput single cell long-read sequencing analyses of same-cell genotypes and phenotypes in human tumors. Nature Communications. 14(1). 4124–4124. 42 indexed citations
5.
Nelson, Blessie Elizabeth, Jason T. Huse, Behrang Amini, et al.. (2023). Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma. npj Precision Oncology. 7(1). 47–47. 3 indexed citations
6.
Malgulwar, Prit Benny, Carla Danussi, W. Evan Johnson, et al.. (2023). Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma. Neuro-Oncology. 26(1). 55–67. 10 indexed citations
7.
Walsh, Kyle M., Corey Neff, Melissa L. Bondy, et al.. (2022). Influence of county-level geographic/ancestral origin on glioma incidence and outcomes in US Hispanics. Neuro-Oncology. 25(2). 398–406. 15 indexed citations
8.
Yang, Jie, Qianghu Wang, Ze-Yan Zhang, et al.. (2022). DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas. Nature Communications. 13(1). 4410–4410. 17 indexed citations
9.
10.
11.
Akkari, Leila, Robert L. Bowman, Florian Klemm, et al.. (2020). Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. Science Translational Medicine. 12(552). 221 indexed citations
12.
Juthani, Rupa, Brian Madajewski, Barney Yoo, et al.. (2019). Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model. Clinical Cancer Research. 26(1). 147–158. 71 indexed citations
13.
Rajappa, Prajwal, William S. Cobb, Yujie Huang, et al.. (2016). Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells. Clinical Cancer Research. 23(12). 3109–3119. 23 indexed citations
14.
Cairncross, J. Gregory, Meihua Wang, Robert B. Jenkins, et al.. (2014). Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH. Journal of Clinical Oncology. 32(8). 783–790. 285 indexed citations
15.
LaPlant, Quincey, Kenneth L. Pitter, Robert J. Young, et al.. (2014). Radiographic Features, Patterns of Treatment Failure, and Clinical Outcomes in 56 Cases of Molecularly Subtyped Glioblastoma Multiforme Patients. International Journal of Radiation Oncology*Biology*Physics. 90(1). S281–S281. 1 indexed citations
16.
Huang, Yujie, Caitlin Hoffman, Prajwal Rajappa, et al.. (2013). Oligodendrocyte Progenitor Cells Promote Neovascularization in Glioma by Disrupting the Blood–Brain Barrier. Cancer Research. 74(4). 1011–1021. 44 indexed citations
17.
Gorovets, Daniel, Kasthuri Kannan, Ronglai Shen, et al.. (2012). IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma. Clinical Cancer Research. 18(9). 2490–2501. 114 indexed citations
18.
Pulvirenti, Teodoro, et al.. (2011). Dishevelled 2 Signaling Promotes Self-Renewal and Tumorigenicity in Human Gliomas. Cancer Research. 71(23). 7280–7290. 82 indexed citations
19.
Fomchenko, Elena I., Joseph D. Dougherty, Karim Y. Helmy, et al.. (2011). Recruited Cells Can Become Transformed and Overtake PDGF-Induced Murine Gliomas In Vivo during Tumor Progression. PLoS ONE. 6(7). e20605–e20605. 59 indexed citations
20.
Becher, Oren J., Dolores Hambardzumyan, Karim Y. Helmy, et al.. (2010). Preclinical Evaluation of Radiation and Perifosine in a Genetically and Histologically Accurate Model of Brainstem Glioma. Cancer Research. 70(6). 2548–2557. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Howard Colman Breakdown of academic impact, for papers by Qiulian Wu Breakdown of academic impact, for papers by Richard J. Gilbertson Breakdown of academic impact, for papers by Anita B. Hjelmeland Breakdown of academic impact, for papers by Gaetano Finocchiaro Breakdown of academic impact, for papers by Frank B. Furnari Breakdown of academic impact, for papers by Marie‐France Hamou Breakdown of academic impact, for papers by Donald M. O’Rourke Breakdown of academic impact, for papers by Robert M. Prins Breakdown of academic impact, for papers by Sheila K. Singh
Rankless by CCL
2026